Area of research
Infectious Diseases · Surgery
Research interest
Research interests include Tuberculosis Research and Epidemiology, HIV/AIDS Research and Interventions, Diagnosis and treatment of tuberculosis, and Pneumonia and Respiratory Infections.
Plasma proteomics for biomarker discovery in childhood tuberculosis
Characterizing Treatment Adherence Trajectories in the endTB Multisite Cohort of Drug-Resistant Tuberculosis Patients: An Application of Group-Based Trajectory Modeling
Conflation of prediction and causality in the TB literature
Effectiveness of a bedaquiline, linezolid, clofazimine ‘core’ for multidrug-resistant TB
Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis
The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort
Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications
Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs
Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion
All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings
Seroprevalence of hepatitis B and hepatitis C among blood donors in Sierra Leone: A multi-year retrospective study
Molecular detection of Mycobacterium tuberculosis from buccal swabs among adult in Peru
Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis
Community health workers improve disease control and medication adherence among patients with diabetes and/or hypertension in Chiapas, Mexico: an observational stepped-wedge study
Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis
Community-Based Accompaniment Mitigates Predictors of Negative Outcomes for Adults on Antiretroviral Therapy in Rural Rwanda
Concordance of <i>Mycobacterium tuberculosis</i> fluoroquinolone resistance testing: implications for treatment
Alcohol, Hospital Discharge, and Socioeconomic Risk Factors for Default from Multidrug Resistant Tuberculosis Treatment in Rural South Africa: A Retrospective Cohort Study